Related Experiment Video
Updated: Apr 29, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Integrated analysis of gene network in childhood leukemia from microarray and pathway databases
Amphun Chaiboonchoe1, Sandhya Samarasinghe2, Don Kulasiri3
1Centre for Advanced Computational Solutions (CfACS), Lincoln University, Lincoln 7647, New Zealand ; Division of Science and Math, New York University Abu Dhabi and Center for Genomics and Systems Biology (CGSB), New York University Abu Dhabi Institute, P.O. Box 129188, Abu Dhabi, UAE.
Glucocorticoids (GCs) impact B- and T-acute lymphoblastic leukaemia (ALL) differently. This study reveals distinct molecular pathways and gene networks affected by GCs in B-ALL versus T-ALL, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Glucocorticoids (GCs) are established therapies for acute lymphoblastic leukaemia (ALL) but their precise molecular mechanisms in different ALL subtypes remain unclear.
- Understanding subtype-specific GC actions is crucial for optimizing treatment strategies in pediatric ALL.
Purpose of the Study:
- To delineate the differential molecular responses of B-cell ALL (B-ALL) and T-cell ALL (T-ALL) to Glucocorticoid (GC) treatment.
- To identify distinct biological processes, molecular pathways, and gene interaction networks influenced by GCs in B-ALL and T-ALL using systems-level analysis.
Main Methods:
- Utilized bioinformatics tools and methods for systems-level analysis of gene expression data.
- Compared biological processes, molecular pathways, and interaction networks affected by GCs in B-ALL and T-ALL.
- Identified differentially expressed GC-regulated genes specific to each ALL subtype.
Main Results:
- GCs induce distinct sets of regulated genes in B-ALL and T-ALL, with minimal overlap.
- Differentially expressed genes in each subtype participate in unique biological processes influenced by GCs.
- Identified subtype-specific gene networks regulated by GCs in ALL.
Conclusions:
- The molecular mechanisms of GC action in ALL are subtype-specific, affecting distinct biological processes and pathways.
- These subtype-specific findings highlight the potential for developing targeted therapeutic strategies for B-ALL and T-ALL.
- The study provides a foundation for identifying novel therapeutic targets based on differential GC responses in ALL subtypes.
